Goff Brian
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Goff Brian. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| AGIO | Chief Executive Officer | Sale | 11,085 | $36.67 | $406,487 | Aug 8, 2025 |
| AGIO | Chief Executive Officer | Option Exercise | 25,527 | — | — | Jun 24, 2025 |
| NTLA | Award / Grant | 8,000 | — | — | Jun 11, 2025 | |
| AGIO | Chief Executive Officer | Sale | 8,794 | $35.54 | $312,539 | Mar 1, 2025 |
| AGIO | Chief Executive Officer | Sale | 11,091 | $42.75 | $474,140 | Aug 8, 2024 |
| NTLA | Award / Grant | 15,409 | — | — | Jun 13, 2024 | |
| AGIO | Chief Executive Officer | Option Exercise | 25,527 | — | — | Jun 5, 2024 |
| AGIO | Chief Executive Officer | Option Exercise | 8,500 | — | — | Mar 5, 2024 |
| AGIO | Chief Executive Officer | Sale | 7,635 | $21.64 | $165,221 | Jan 20, 2024 |
| AGIO | Chief Executive Officer | Option Exercise | 25,527 | — | — | Jan 9, 2024 |
| AGIO | Chief Executive Officer | Option Exercise | 22,691 | — | — | Aug 8, 2023 |
| AGIO | Chief Executive Officer | Sale | 11,449 | $28.36 | $324,694 | Jun 28, 2023 |
| 0000899866 | EVP & Chief Commercial Officer | Disposition | 150,832 | — | — | Jul 21, 2021 |
| 0000899866 | EVP & Chief Commercial Officer | Award / Grant | 29,501 | — | — | Jul 14, 2021 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 1,086 | $177.00 | $192,222 | Jun 8, 2021 |
| 0000899866 | EVP & Chief Commercial Officer | Award / Grant | 24,473 | — | — | Feb 28, 2021 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 3,261 | $157.96 | $515,108 | Dec 16, 2020 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 1,642 | $114.61 | $188,190 | Jun 8, 2020 |
| 0000899866 | EVP & Chief Commercial Officer | Award / Grant | 10,880 | — | — | Mar 2, 2020 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 1,594 | $102.97 | $164,134 | Feb 7, 2020 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 1,643 | $118.61 | $194,876 | Jun 7, 2019 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 670 | $132.93 | $89,063 | Feb 28, 2019 |
| 0000899866 | EVP & Chief Commercial Officer | Award / Grant | 9,428 | — | — | Feb 28, 2019 |
| 0000899866 | EVP & Chief Commercial Officer | Tax Withholding | 1,596 | $119.57 | $190,834 | Feb 7, 2019 |
| 0000899866 | EVP & Chief Commercial Officer | Sale | 1,645 | $118.53 | $194,982 | Jun 8, 2018 |
| 0000899866 | EVP & Chief Commercial Officer | Award / Grant | 8,940 | — | — | Feb 28, 2018 |
| 0000899866 | EVP & Chief Commercial Officer | Sale | 1,651 | $116.31 | $192,028 | Feb 6, 2018 |
| 0000899866 | EVP & Chief Commercial Officer | Award / Grant | 14,719 | — | — | Jun 7, 2017 |
| 0001620546 | EVP and President, Hematology | Disposition | 70,047 | — | — | Jun 3, 2016 |
| 0001620546 | EVP and President, Hematology | Tax Withholding | 267 | $39.74 | $10,611 | Mar 7, 2016 |
| 0001620546 | EVP and President, Hematology | Tax Withholding | 303 | $39.47 | $11,959 | Mar 3, 2016 |
| 0001620546 | EVP and President, Hematology | Award / Grant | 508 | — | — | Feb 15, 2016 |
| 0001620546 | EVP and President, Hematology | Award / Grant | 157 | — | — | Aug 11, 2015 |
| 0001620546 | EVP and President, Hematology | Other | 28,154 | — | — | Jul 1, 2015 |